Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Encysive Pharmaceuticals (ENCY) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (5)	12/19/2005 1:16:44 PM
From: rkrw	Read Replies (1) \| Respond to of 205

Tuck, earlier stage patients will be on combos, no question about it. But I'm not quite certain the invasive remodoulin will be desirable for early stage patients. What you might see is inhaled remodoulin (I think it's a couple of years from nda filing) or ventavis used in combo with the tracleers and viagras earlier rather than later. And to make matters even more complicated, apparently gleevec is showing strong anecdotal efficacy.